McMaster University is a world leader in the field of medical isotopes, which are used to image and treat conditions like heart disease and cancer.
Our staff produce and ship these isotopes around the world, providing treatment for more than 70,000 cancer patients every year.
With a particular focus on the development of new medical isotope-based drugs, we aim to provide Canadians with the next generation of life-saving medical isotope products.
Iodine-125 is commonly used in brachytherapy to treat prostate cancer.
Lutetium-177 is used to treat a variety of cancers.
More on radioisotopes
Cancer is a leading cause of death globally, with rates rising among younger people. What is McMaster University doing about it? We’re using nuclear science to fight back.
McMaster News ➚
News
The Globe and Mail ➚
CBC News ➚
Brighter World ➚
Innovation News Network ➚
Daily News ➚
Event
Health
Innovating Canada ➚
United Nations Academic Impact ➚
Education, Health, Materials, News, Nuclear
Health, News